Hepatobiliary Surgery — MCQs

Hepatobiliary Surgery Indian Medical PG Practice Questions and MCQs

Question 191: Which of the following is NOT a treatment for common bile duct stones?

A. Endoscopic papillotomy
B. ERCP (Endoscopic Retrograde Cholangiopancreatography)
C. Choledochotomy
D. Ursodeoxycholic acid (Correct Answer)

Explanation: **Explanation:** The management of common bile duct (CBD) stones (choledocholithiasis) focuses on the mechanical removal of the obstruction to prevent complications like cholangitis or pancreatitis. **Why Ursodeoxycholic acid (UDCA) is the correct answer:** UDCA is a hydrophilic bile acid used for the **medical dissolution of small, radiolucent cholesterol gallstones** located in a functioning **gallbladder**. It is ineffective for CBD stones because these are often pigmented or mixed, and the drug requires a long duration (months) to work, which is unsafe in the context of CBD obstruction where urgent decompression is usually required. **Analysis of other options:** * **Endoscopic Papillotomy & ERCP:** ERCP with sphincterotomy (papillotomy) and stone extraction (using baskets or balloons) is currently the **gold standard** and first-line treatment for CBD stones. * **Choledochotomy:** This is the surgical opening of the CBD to remove stones. It is performed either laparoscopically or via open surgery (often with T-tube placement) when endoscopic methods fail or when a cholecystectomy is being performed simultaneously. **High-Yield Clinical Pearls for NEET-PG:** * **Investigation of Choice (IOC):** MRCP (Non-invasive, 95% sensitivity). * **Gold Standard Treatment:** ERCP with stone extraction. * **Charcot’s Triad:** Fever, jaundice, and RUQ pain (indicates ascending cholangitis due to CBD stones). * **Reynold’s Pentad:** Charcot’s triad + Hypotension + Altered mental status (indicates surgical emergency). * **Stone Types:** Primary CBD stones are usually **Brown pigment stones** (formed due to stasis/infection), while secondary stones are usually **Cholesterol stones** migrated from the gallbladder.

Question 192: Which of the following statements is not true regarding Milan's criteria?

A. Single tumor <5 cm in size
B. Up to 3 nodules, each <3 cm in size
C. Fewer than 5 nodules (Correct Answer)
D. No extrahepatic spread

Explanation: **Explanation:** The **Milan Criteria** are the gold standard guidelines used to determine the eligibility of patients with Hepatocellular Carcinoma (HCC) for **Orthotopic Liver Transplantation (OLT)**. These criteria were established to select patients who would achieve post-transplant survival rates comparable to those transplanted for non-malignant conditions. **Why Option C is the correct answer (Not True):** The Milan Criteria do not allow for "fewer than 5 nodules." The criteria strictly limit the number of tumors to a **maximum of three** if they are small. Any patient with four or more nodules falls outside the Milan Criteria, regardless of the size of the nodules. **Analysis of Incorrect Options (True Statements):** * **Option A (Single tumor <5 cm):** This is the primary criterion for solitary lesions. A single HCC up to 5 cm in diameter is considered within the "Milan-in" zone. * **Option B (Up to 3 nodules, each <3 cm):** For multifocal disease, the criteria allow for a maximum of 3 nodules, provided none exceed 3 cm in diameter. * **Option D (No extrahepatic spread):** This is a mandatory requirement. The presence of extrahepatic metastasis or **macrovascular invasion** (e.g., portal vein thrombosis) is an absolute contraindication for transplantation under these criteria. **High-Yield Clinical Pearls for NEET-PG:** * **UCSF Criteria:** An expansion of Milan, allowing a single lesion up to 6.5 cm or 2–3 lesions up to 4.5 cm (total diameter ≤8 cm). * **Bridging Therapy:** While waiting for a transplant, patients within Milan criteria often undergo TACE or RFA to prevent "dropout" due to tumor progression. * **Survival:** Patients meeting Milan criteria have a 5-year survival rate exceeding 70% post-transplant.

Question 193: An increased incidence of cholangiocarcinoma is seen in all of the following except?

A. Hydatid cyst of liver (Correct Answer)
B. Polycystic disease of liver
C. Sclerosing cholangitis
D. Liver flukes

Explanation: **Explanation:** Cholangiocarcinoma (CCA) is a malignancy arising from the biliary epithelium. Its development is strongly associated with conditions causing **chronic biliary inflammation, stasis, and bile duct injury.** **Why Hydatid Cyst is the correct answer:** **Hydatid cyst (Option A)** is caused by the parasite *Echinococcus granulosus*. While it can cause complications like rupture into the biliary tree or secondary infection, it is **not** a premalignant condition and does not increase the risk of cholangiocarcinoma. **Analysis of Incorrect Options (Risk Factors for CCA):** * **Polycystic Liver Disease (Option B):** Fibropolycystic liver diseases, including Caroli’s disease and congenital hepatic fibrosis, involve malformations of the ductal plate. These lead to bile stasis and chronic inflammation, significantly increasing the risk of CCA (up to 15%). * **Sclerosing Cholangitis (Option C):** Primary Sclerosing Cholangitis (PSC) is one of the strongest risk factors for CCA in the Western world. The chronic fibro-obliterative process leads to malignant transformation in approximately 10-15% of patients. * **Liver Flukes (Option D):** Infection with *Opisthorchis viverrini* and *Clonorchis sinensis* (endemic in SE Asia) is a major risk factor. These parasites reside in the bile ducts, causing chronic mechanical irritation and secreting pro-inflammatory cytokines. **NEET-PG High-Yield Pearls:** * **Most common risk factor worldwide:** Liver fluke infestation. * **Most common risk factor in the West:** Primary Sclerosing Cholangitis. * **Other risk factors:** Choledochal cysts (Type I, IV), Thorotrast exposure, and Hepatolithiasis (recurrent pyogenic cholangitis). * **Tumor Marker:** CA 19-9 is the most commonly used marker for monitoring and diagnosis. * **Klatskin Tumor:** A hilar cholangiocarcinoma occurring at the confluence of the right and left hepatic ducts.

Question 194: All are true about hepatic adenoma except?

A. Benign proliferative disorder of hepatocytes.
B. Hepatic architecture is maintained. (Correct Answer)
C. CECT shows peripheral hypervascularization.
D. Treatment is excision.

Explanation: **Explanation:** **Hepatic Adenoma (HA)** is a benign, solid neoplasm of the liver primarily seen in young women with a history of oral contraceptive pill (OCP) use. **1. Why Option B is the Correct Answer (The False Statement):** In Hepatic Adenoma, the **normal hepatic architecture is NOT maintained**. Histologically, it consists of sheets of hepatocytes without the presence of normal portal tracts, bile ducts, or a central venous system. This lack of supporting structure makes the lesion prone to hemorrhage. In contrast, Focal Nodular Hyperplasia (FNH) maintains a more organized (though abnormal) architecture with a central stellate scar. **2. Analysis of Other Options:** * **Option A:** It is indeed a **benign proliferative disorder** of hepatocytes, often linked to hormonal stimulation (estrogen) or anabolic steroids. * **Option C:** On CECT, HA typically shows **peripheral hypervascularization** with centripetal filling during the arterial phase. They are hyperenhancing because they are supplied by unpaired arteries. * **Option D:** **Excision is the treatment of choice** for symptomatic lesions, lesions >5 cm, or those in males, due to the high risk of spontaneous rupture (leading to hemoperitoneum) and a small but significant risk of malignant transformation to Hepatocellular Carcinoma (HCC). **High-Yield Clinical Pearls for NEET-PG:** * **Risk Factors:** OCP use (most common), Anabolic steroids, Glycogen storage diseases (Type I and III). * **Subtypes:** HNF-1α inactivated (low risk), Inflammatory (most common, high bleed risk), and **β-catenin activated** (highest risk of malignancy). * **Imaging:** "Cold" on sulfur colloid scan (due to lack of Kupffer cells), unlike FNH which is "hot" or "isointense." * **Management:** Stop OCPs first; if >5cm or persistent, proceed to surgical resection.

Question 195: Which of the following is NOT a curative treatment modality for hepatocellular carcinoma?

A. Transarterial Chemoembolization (TACE) (Correct Answer)
B. Radiofrequency ablation
C. Percutaneous Ethanol Injection
D. Resection

Explanation: **Explanation:** In the management of Hepatocellular Carcinoma (HCC), treatment modalities are classified into **Curative** (aiming for complete eradication) and **Palliative** (aiming to control growth and prolong survival). **Why TACE is the correct answer:** **Transarterial Chemoembolization (TACE)** is considered a **palliative** treatment. It involves the delivery of chemotherapeutic agents directly into the hepatic artery followed by embolization to induce ischemic necrosis. While it is the standard of care for intermediate-stage HCC (BCLC Stage B), it is not curative because it rarely achieves complete pathological necrosis of the entire tumor volume. **Why the other options are incorrect:** * **Resection (Option D):** This is the gold standard curative treatment for patients with solitary tumors and preserved liver function (Child-Pugh A) without portal hypertension. * **Radiofrequency Ablation (RFA) (Option B):** A curative thermal ablative technique. For tumors <3 cm, RFA achieves survival rates comparable to surgical resection. * **Percutaneous Ethanol Injection (PEI) (Option C):** A curative chemical ablative technique. Though largely replaced by RFA, it remains an effective curative option for small tumors, especially when located near major vessels where RFA might cause a "heat-sink" effect. **Clinical Pearls for NEET-PG:** * **Milan Criteria:** Used to select HCC patients for **Liver Transplantation** (the ultimate curative treatment): Solitary nodule ≤5 cm or up to 3 nodules each ≤3 cm. * **BCLC Staging:** The most widely used system for HCC management. * **Sorafenib:** A multi-kinase inhibitor used as first-line systemic therapy for advanced, non-resectable HCC. * **Fibrolamellar HCC:** Occurs in young adults without cirrhosis; has a better prognosis and normal AFP levels.

Question 196: Which of the following statements regarding gallbladder dilatation is FALSE?

A. Dilatation of the gallbladder with jaundice is unlikely from gallstones.
B. Dilatation of the gallbladder with jaundice is typically due to gallstones. (Correct Answer)
C. Dilatation of a gallbladder with jaundice can be due to periampullary carcinoma.
D. Dilatation of the gallbladder may be present in Mirizzi syndrome.

Explanation: This question tests your understanding of **Courvoisier’s Law**, a fundamental principle in hepatobiliary surgery. ### **Explanation of the Correct Answer (B)** Option B is the **FALSE** statement. According to Courvoisier’s Law, if the gallbladder is palpable (dilated) in a patient with obstructive jaundice, the cause is **unlikely to be gallstones**. This is because chronic cholelithiasis (gallstones) leads to recurrent inflammation and fibrosis, making the gallbladder wall shrunken, scarred, and unable to distend. Therefore, a dilated gallbladder in the presence of jaundice typically points toward a **malignant obstruction** of the common bile duct (e.g., pancreatic head cancer). ### **Analysis of Other Options** * **Option A:** This is a correct statement of Courvoisier’s Law. Gallstones usually cause a fibrotic, non-distensible gallbladder. * **Option C:** This is true. Periampullary carcinoma causes a slow, progressive distal obstruction. Since the gallbladder wall is usually healthy (not fibrotic), it distends to accommodate the back-pressure of bile. * **Option D:** This is true. Mirizzi syndrome involves an extrinsic compression of the Common Hepatic Duct by a stone impacted in the cystic duct/Hartmann’s pouch. In **Type II-IV** Mirizzi, or if the obstruction is distal enough, the gallbladder can occasionally appear distended or inflamed, though it is often considered an exception to the law. ### **High-Yield NEET-PG Pearls** * **Courvoisier’s Law:** Palpable GB + Jaundice = Malignancy (usually Pancreatic Head CA). * **Exceptions to Courvoisier’s Law (GB palpable with stones):** 1. Double impaction (one stone in cystic duct, one in CBD). 2. Oriental Cholangiohepatitis (Recurrent Pyogenic Cholangitis). 3. Mucocele of the gallbladder (though jaundice may be absent). * **Most common cause of malignant obstructive jaundice:** Carcinoma of the head of the pancreas. * **Most common cause of painless obstructive jaundice:** Periampullary carcinoma.

Question 197: By definition, pigment stones contain what percentage of cholesterol?

A. <10%
B. <20%
C. <30% (Correct Answer)
D. <60%

Explanation: **Explanation:** Gallstones are primarily classified into **Cholesterol stones** and **Pigment stones** (Black or Brown) based on their chemical composition. **1. Why <30% is correct:** According to the standard classification (often cited in textbooks like Bailey & Love and Sabiston), gallstones are defined by their cholesterol content: * **Cholesterol Stones:** Contain >70% cholesterol by weight. * **Mixed Stones:** Contain 30% to 70% cholesterol. * **Pigment Stones:** By definition, these contain **less than 30% cholesterol**. They are primarily composed of calcium bilirubinate, polymers of bilirubin, and inorganic calcium salts. **2. Analysis of Incorrect Options:** * **<10% (Option A):** While some "pure" pigment stones may have very low cholesterol, the formal diagnostic threshold for the category is higher. * **<20% (Option B):** This is an incorrect threshold; 30% is the internationally recognized cut-off for distinguishing pigment from mixed stones. * **<60% (Option D):** This range would include "Mixed stones" (30-70%), which are pathophysiologically distinct from true pigment stones. **3. NEET-PG High-Yield Clinical Pearls:** * **Black Pigment Stones:** Associated with **chronic hemolysis** (e.g., Hereditary Spherocytosis, Sickle Cell Anemia) and Cirrhosis. They are usually found in the gallbladder. * **Brown Pigment Stones:** Associated with **biliary stasis and infection** (e.g., *E. coli*, *Clonorchis sinensis*). They often form *de novo* in the bile ducts. * **Radiopacity:** Most pigment stones (especially black) are **radiopaque** (visible on X-ray) due to calcium salts, whereas pure cholesterol stones are radiolucent. * **Enzyme Link:** Brown stones form due to the action of bacterial **beta-glucuronidase**, which deconjugates bilirubin.

Question 198: What is the true color of a cholesterol gallstone?

A. Black
B. Brown
C. Dark yellow
D. Pale yellow (Correct Answer)

Explanation: **Explanation:** Gallstones are primarily classified based on their chemical composition into cholesterol stones and pigment stones. **1. Why Pale Yellow is Correct:** Pure cholesterol stones are composed of over 50-70% crystalline cholesterol monohydrate. In its pure form, cholesterol is a **pale yellow** or whitish-yellow substance. These stones are typically large, solitary, and have a smooth or finely granular surface. They form when bile becomes supersaturated with cholesterol (lithogenic bile), leading to nucleation and stone growth. **2. Why Other Options are Incorrect:** * **Black (Option A):** These are **Black Pigment Stones**, composed of calcium bilirubinate and polymers. They are associated with chronic hemolysis (e.g., Hereditary Spherocytosis, Sickle Cell Anemia) and cirrhosis. They are typically small, multiple, and radiopaque. * **Brown (Option B):** These are **Brown Pigment Stones**, associated with **biliary stasis and infection** (e.g., *E. coli*, *Clonorchis sinensis*). They contain calcium salts of unconjugated bilirubin and fatty acids. They are soft, greasy, and often form within the bile ducts (primary CBD stones). * **Dark Yellow (Option C):** While mixed stones (the most common type) can appear darker due to the inclusion of calcium salts and bile pigments, the "true" or "pure" cholesterol stone is characterized by its pale, crystalline appearance. **Clinical Pearls for NEET-PG:** * **Most common type of stone:** Mixed stones (contain cholesterol, bile pigments, and calcium). * **Radiopacity:** 80-90% of cholesterol stones are **radiolucent** (cannot be seen on X-ray). Black pigment stones are the most radiopaque. * **Risk Factors:** Remember the **5 F's**: Fat, Female, Fertile, Forty, and Fair. * **Investigation of Choice:** Transabdominal Ultrasonography (USG) is the gold standard for diagnosis.

Question 199: The Charcot triad includes all of the following except?

A. Abdominal pain
B. Fever
C. Jaundice
D. Mental obtundation (Correct Answer)

Explanation: **Explanation:** The correct answer is **Mental obtundation**. This question tests the ability to distinguish between **Charcot’s Triad** and **Reynold’s Pentad**, both of which are critical clinical markers for **Acute Cholangitis**. **1. Why Mental Obtundation is the correct answer:** Charcot’s Triad consists of three classic signs: **Fever (usually with chills/rigors), Jaundice, and Right Upper Quadrant (RUQ) Abdominal Pain.** Mental obtundation (altered mental status) is not part of this triad. Instead, it is a component of **Reynold’s Pentad**, which indicates a more severe, life-threatening progression of obstructive jaundice and sepsis. **2. Analysis of Incorrect Options:** * **Abdominal Pain (A):** Typically located in the RUQ, this is a hallmark of biliary obstruction and a core component of the triad. * **Fever (B):** Usually the most common presenting symptom (90% of cases), reflecting the underlying bacterial infection (most commonly *E. coli*). * **Jaundice (C):** Results from the backup of bile due to obstruction (e.g., choledocholithiasis), completing the classic triad. **Clinical Pearls for NEET-PG:** * **Reynold’s Pentad:** Charcot’s Triad + **Hypotension (Shock)** + **Altered Mental Status**. It signifies "suppurative cholangitis" and requires urgent biliary decompression. * **Diagnostic Utility:** While Charcot’s triad is highly specific for cholangitis, its sensitivity is low (approx. 50-70%). * **Management:** The definitive treatment for acute cholangitis is **ERCP** (Endoscopic Retrograde Cholangiopancreatography) for biliary drainage, along with IV antibiotics and fluids.

Question 200: A 50-year-old patient presents with bile leakage from the mid-clavicular port site on the first post-operative day after laparoscopic cholecystectomy. An abdominal ultrasound has been performed. What is the most appropriate next step in the management of this patient?

A. Endoscopic retrograde cholangiopancreatography (ERCP) with stenting (Correct Answer)
B. Laparoscopic exploration and repair
C. Observation
D. Percutaneous drainage and stent placement

Explanation: **Explanation:** The clinical presentation of bile leakage through a port site following laparoscopic cholecystectomy suggests a post-operative biliary leak, most commonly arising from the **Cystic Duct Stump** or a minor **Duct of Luschka**. **1. Why ERCP with Stenting is the Correct Choice:** The primary goal in managing a bile leak is to decrease the pressure gradient across the Sphincter of Oddi. **ERCP with biliary stenting (with or without sphincterotomy)** achieves this by providing a low-resistance pathway for bile to flow into the duodenum. This promotes the spontaneous closure of the leak site. Since the patient is stable and an ultrasound has likely ruled out major collections or complete transection, ERCP is both diagnostic (identifies the site) and therapeutic. **2. Why Other Options are Incorrect:** * **Laparoscopic exploration:** This is generally reserved for patients with generalized peritonitis, complete bile duct transection, or when endoscopic/radiological interventions fail. * **Observation:** Bile leaks rarely resolve spontaneously without intervention and can lead to biliary peritonitis or intra-abdominal collections if left untreated. * **Percutaneous drainage:** While useful for draining localized collections (bilomas), it does not address the underlying pressure gradient causing the leak. **Clinical Pearls for NEET-PG:** * **Most common site of post-cholecystectomy bile leak:** Cystic duct stump. * **Strasberg Classification:** Used to grade bile duct injuries (Type A is a leak from the cystic duct or Luschka duct). * **Initial Investigation of Choice:** Ultrasound (to look for collections). * **Gold Standard/Definitive Management for minor leaks:** ERCP. * **Major Duct Injury (Transection):** Requires surgical reconstruction (Roux-en-Y Hepaticojejunostomy).

Practice by Chapter

Liver Anatomy and Physiology

Practice Questions

Benign Liver Lesions

Practice Questions

Liver Abscess

Practice Questions

Hepatocellular Carcinoma

Practice Questions

Metastatic Liver Disease

Practice Questions

Cirrhosis and Portal Hypertension

Practice Questions

Liver Trauma

Practice Questions

Cholelithiasis and Cholecystitis

Practice Questions

Choledocholithiasis

Practice Questions

Biliary Tract Tumors

Practice Questions

ERCP and Its Complications

Practice Questions

Liver Transplantation Basics

Practice Questions

Want unlimited practice?

Get full access to all questions, explanations, and performance tracking.

Start For Free